Curis Inc (CRIS) Stock Price, Quote & News

Company Profile

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes fo...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 503 6500

Website: www.curis.com

Address:

Building C, Suite 500 128 Spring Street, Lexington, United States

LodiDodiWeLikesToParty Aug. 18 at 8:49 PM

$CRIS just look at the history.

0 · Reply

YouVSYou Aug. 18 at 4:36 AM

$IVDA has 12.9M warrants around $0.35, $GXAI just created 6M new $0.95 warrants, $CRIS just completed a heavily dilutive offering, and $WCT.X has a proposed 50M-share offering

0 · Reply

Casualtradess Aug. 17 at 3:34 PM

$CRIS December data readout is a major upcoming catalyst…

0 · Reply

StocktwitsNews Aug. 17 at 11:02 AM

CRIS Q2 2026 Earnings Summary $CRIS https://stocktwits.com/news/earnings/ai summaries/cris-q2-2026-earnings-summary/cZYGGxJRJKz

0 · Reply

StocktwitsEarnings Aug. 17 at 7:57 AM

$CRIS Q2 '26 Earnings Results & Recap Reported GAAP EPS of -$4.02 up 70.46% YoY

0 · Reply

LodiDodiWeLikesToParty Aug. 15 at 4:32 AM

$CRIS Neverending theft of shares. My once 3,881 shares reduced to just 9 shares. Make it right, you sacks of s##t. I believe everyone is tired of this treatment to your shareholders.

0 · Reply

BioHuntingTwits Aug. 14 at 5:05 PM

$CRIS

0 · Reply

Zaksab Aug. 13 at 6:11 PM

$CRIS To price just 50% ahead of the minimum bid requirement 8 weeks after a 1-for-20 RS…I thought I’d seen everything…

0 · Reply

realditzy Aug. 13 at 2:05 PM

$CRIS break 2 ?

0 · Reply

NGupup Aug. 13 at 1:42 PM

$CRIS 🔥🔥

0 · Reply

Curis announces pricing of $5.6M public offering

Aug 14, 2026, 4:00 PM EDT - 4 days ago

Curis Quarterly report: Q2 2026

Aug 13, 2026, 8:00 AM EDT - 6 days ago

Curis, Inc. Announces Pricing of $5.6 Million Public Offering

2026-08-10T21:35:09.000Z - 8 days ago

Curis files to sell 3.73M shares of common stock, warrants

Aug 10, 2026, 8:00 AM EDT - 9 days ago

Curis Registration statement: Registration filing

2026-07-30T12:16:16.000Z - 20 days ago

Curis doses first five patients in TakeAim CLL study

Jul 30, 2026, 8:00 AM EDT - 20 days ago

Curis Doses First Five Patients in TakeAim CLL Study

2026-07-24T10:06:12.000Z - 26 days ago

Curis price target raised to $43 from $17 at H.C. Wainwright

Jul 22, 2026, 8:30 AM EDT - 4 weeks ago

Curis Transcript: Study update

Jul 22, 2026, 8:30 AM EDT - 4 weeks ago

Curis Press release: Study update

Jul 22, 2026, 8:30 AM EDT - 4 weeks ago

Curis Slides: Study update

2026-07-22T11:05:25.000Z - 4 weeks ago

Curis to report clinical data in the TakeAim Lymphoma study

Jul 22, 2026, 7:00 AM EDT - 4 weeks ago

Curis Announces Positive Emavusertib Update

Jul 15, 2026, 7:00 AM EDT - 5 weeks ago

Curis Slides: Corporate presentation

2026-07-06T13:35:18.000Z - 6 weeks ago

Curis consents first six patients in TakeAim CLL study

Jul 6, 2026, 9:30 AM EDT - 6 weeks ago

Curis Consents First Six Patients in TakeAim CLL Study

2026-07-02T23:50:20.000Z - 6 weeks ago

Curis trading halted, news pending

2026-06-26T13:50:10.000Z - 7 weeks ago

Curis announces eleven active clinical sites in TakeAim CLL study

Jun 26, 2026, 9:42 AM EDT - 7 weeks ago

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

Jun 25, 2026, 11:00 AM EDT - 7 weeks ago

Curis Transcript: EGM 2026

Jun 5, 2026, 8:00 AM EDT - 2 months ago

Curis Proxy statement: Proxy filing

Jun 5, 2026, 7:00 AM EDT - 2 months ago

Curis Slides: Corporate presentation

May 22, 2026, 8:00 AM EDT - 3 months ago

Curis Proxy statement: Proxy filing

May 19, 2026, 11:00 AM EDT - 3 months ago

Curis Transcript: AGM 2026

2026-05-12T22:10:48.000Z - 3 months ago

Curis reports Q1 EPS ($1.25), consensus (29c)

2026-05-12T22:07:01.000Z - 3 months ago

Curis sees cash and proceeds enough for operations into second half of FY27

May 12, 2026, 4:30 PM EDT - 3 months ago

Curis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Curis Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Curis Quarterly report: Q1 2026

May 12, 2026, 4:00 PM EDT - 3 months ago

Curis Provides First Quarter 2026 Business Update

May 5, 2026, 5:11 PM EDT - 3 months ago

Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Curis Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 4 months ago

Curis Proxy statement: Proxy filing

Mar 30, 2026, 7:00 AM EDT - 5 months ago

Curis Slides: Corporate presentation

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Curis Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Curis Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Curis Earnings release: Q4 2025

Mar 19, 2026, 4:00 PM EDT - 5 months ago

Curis Provides Fourth Quarter 2025 Business Update

Mar 17, 2026, 11:00 AM EDT - 5 months ago

Curis Transcript: EGM 2026

Mar 12, 2026, 4:27 PM EDT - 5 months ago

Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

Feb 19, 2026, 7:00 AM EST - 6 months ago

Curis Proxy statement: Proxy Filing

Feb 13, 2026, 7:00 AM EST - 6 months ago

Curis Registration statement: Registration Filing

Feb 9, 2026, 7:00 AM EST - 6 months ago

Curis Proxy statement: Proxy Filing

Jan 9, 2026, 8:00 AM EST - 7 months ago

Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Jan 7, 2026, 8:45 AM EST - 8 months ago

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Dec 9, 2025, 8:00 AM EST - 9 months ago

Curis Provides Updated Data from its Frontline AML Triplet Study

Nov 14, 2025, 9:26 AM EST - 9 months ago

Curis to Present at Upcoming 30th Annual SNO Meeting

Nov 6, 2025, 4:30 PM EST - 10 months ago

Curis Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Curis Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Curis Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 10 months ago

Curis Provides Third Quarter 2025 Business Update

Oct 30, 2025, 4:00 PM EDT - 10 months ago

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025

Oct 3, 2025, 4:00 PM EDT - 11 months ago

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sep 10, 2025, 10:00 AM EDT - 1 year ago

Curis Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 9:45 AM EDT - 1 year ago

Curis Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 10:43 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conferences in September

Aug 11, 2025, 8:00 AM EDT - 1 year ago

Curis Registration statement: Registration Filing

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Curis Quarterly report: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Curis Provides Second Quarter 2025 Business Update

Jul 29, 2025, 8:30 AM EDT - 1 year ago

Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025

Jul 2, 2025, 8:32 AM EDT - 1 year ago

Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement

May 7, 2025, 8:00 AM EDT - 1 year ago

Curis Registration statement: Registration Filing

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Curis Provides First Quarter 2025 Business Update

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Curis Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Curis Proxy statement: Proxy Filing

Apr 9, 2025, 4:30 PM EDT - 1 year ago

Curis Transcript: Jones Healthcare and Technology Innovation Conference 2025

Apr 2, 2025, 4:05 PM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conference in April

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q4 2024

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Annual report: Q4 2024

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings release: Q4 2024

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Curis Provides Fourth Quarter 2024 Business Update

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Curis Proxy statement: Proxy Filing

Mar 28, 2025, 4:07 PM EDT - 1 year ago

Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025

Dec 23, 2024, 7:00 AM EST - 1 year ago

Curis Registration statement: Registration Filing

Dec 10, 2024, 8:00 AM EST - 1 year ago

Curis Announces Additional Data from TakeAim Leukemia Study

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Quarterly report: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Earnings release: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

Curis Provides Third Quarter 2024 Business Update

Nov 7, 2024, 8:00 AM EST - 1 year ago

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Oct 29, 2024, 6:04 AM EDT - 1 year ago

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Sep 23, 2024, 8:30 AM EDT - 2 years ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 17, 2024, 3:05 PM EDT - 2 years ago

Curis Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 17, 2024, 7:30 AM EDT - 2 years ago

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 11, 2024, 1:00 PM EDT - 2 years ago

Curis Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Curis Quarterly report: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings release: Q2 2024

Aug 1, 2024, 8:00 AM EDT - 2 years ago

Curis Provides Second Quarter 2024 Financial and Operating Update

Jul 25, 2024, 8:00 AM EDT - 2 years ago

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Jul 10, 2024, 7:30 AM EDT - 2 years ago

Curis to Present at Upcoming Healthcare Conference in July

May 14, 2024, 4:30 PM EDT - 2 years ago

Curis Transcript: Status Update

May 10, 2024, 8:00 AM EDT - 2 years ago

Curis to Present Updated Data from the TakeAim Leukemia Study

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Quarterly report: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings release: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Curis Provides First Quarter 2024 Business Update

Apr 30, 2024, 8:00 AM EDT - 2 years ago

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Curis Proxy statement: Proxy Filing

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Curis Proxy statement: Proxy Filing

Apr 8, 2024, 12:45 PM EDT - 2 years ago

Curis Transcript: 23rd Annual Needham Virtual Healthcare Conference

Apr 5, 2024, 7:00 AM EDT - 2 years ago

Curis Slides: Corporate Presentation

Apr 4, 2024, 7:30 AM EDT - 2 years ago

Curis to Present at Upcoming Healthcare Conferences in April

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Curis Proxy statement: Proxy Filing

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Earnings Call Transcript: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Annual report: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Earnings release: Q4 2023

Feb 8, 2024, 8:00 AM EST - 2 years ago

Curis Provides Fourth Quarter 2023 Business Update

Feb 8, 2024, 7:00 AM EST - 2 years ago

Curis Registration statement: Registration Filing

Feb 1, 2024, 8:00 AM EST - 2 years ago

Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024

Dec 12, 2023, 8:00 AM EST - 2 years ago

Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

Dec 11, 2023, 8:00 AM EST - 2 years ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

Dec 6, 2023, 8:00 AM EST - 2 years ago

Curis Announces Three Presentations at ASH

Dec 5, 2023, 8:00 AM EST - 2 years ago

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

Nov 17, 2023, 9:04 AM EST - 2 years ago

Curis's stock rises as analysts see ‘the next Pharmacyclics'

Nov 2, 2023, 8:30 AM EDT - 3 years ago

Curis Earnings Call Transcript: Q3 2023

Nov 2, 2023, 8:30 AM EDT - 3 years ago

Curis Quarterly report: Q3 2023

Nov 2, 2023, 8:30 AM EDT - 3 years ago

Curis Earnings release: Q3 2023

Nov 2, 2023, 8:00 AM EDT - 3 years ago

Curis Provides Third Quarter 2023 Business Update

Oct 26, 2023, 8:30 AM EDT - 3 years ago

Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023

Sep 12, 2023, 8:00 AM EDT - 3 years ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Aug 18, 2023, 8:00 AM EDT - 3 years ago

Curis Proxy statement: Proxy Filing

Aug 4, 2023, 8:00 AM EDT - 3 years ago

Curis Proxy statement: Proxy Filing

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings Call Transcript: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Quarterly report: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings release: Q2 2023

Aug 3, 2023, 4:01 PM EDT - 3 years ago

Curis Provides Second Quarter 2023 Business Update

LodiDodiWeLikesToParty Aug. 18 at 8:49 PM

$CRIS just look at the history.

0 · Reply

YouVSYou Aug. 18 at 4:36 AM

$IVDA has 12.9M warrants around $0.35, $GXAI just created 6M new $0.95 warrants, $CRIS just completed a heavily dilutive offering, and $WCT.X has a proposed 50M-share offering

0 · Reply

Casualtradess Aug. 17 at 3:34 PM

$CRIS December data readout is a major upcoming catalyst…

0 · Reply

StocktwitsNews Aug. 17 at 11:02 AM

CRIS Q2 2026 Earnings Summary $CRIS https://stocktwits.com/news/earnings/ai summaries/cris-q2-2026-earnings-summary/cZYGGxJRJKz

0 · Reply

StocktwitsEarnings Aug. 17 at 7:57 AM

$CRIS Q2 '26 Earnings Results & Recap Reported GAAP EPS of -$4.02 up 70.46% YoY

0 · Reply

LodiDodiWeLikesToParty Aug. 15 at 4:32 AM

$CRIS Neverending theft of shares. My once 3,881 shares reduced to just 9 shares. Make it right, you sacks of s##t. I believe everyone is tired of this treatment to your shareholders.

0 · Reply

BioHuntingTwits Aug. 14 at 5:05 PM

$CRIS

0 · Reply

Zaksab Aug. 13 at 6:11 PM

$CRIS To price just 50% ahead of the minimum bid requirement 8 weeks after a 1-for-20 RS…I thought I’d seen everything…

0 · Reply

realditzy Aug. 13 at 2:05 PM

$CRIS break 2 ?

0 · Reply

NGupup Aug. 13 at 1:42 PM

$CRIS 🔥🔥

0 · Reply

MaiXin Aug. 13 at 12:33 PM

$CRIS https://www.prnewswire.com/news-releases/curis-inc-announces-pricing-of-5-6-million-public-offering-302850642.html

1 · Reply

EvenBetter Aug. 13 at 11:56 AM

$CRIS is there an Ending?

0 · Reply

0what Aug. 13 at 1:42 AM

$CRIS , got stuck here with a few shares. SEC S-1, toxic warrant completely trashed valuation. Next could be delisting, Chapter 11, asset sales or if we're lucky, a pharma partnership. The only real path to salvation is an early positive data readout that attracts a licensing deal or a buyout.

0 · Reply

TL_Trades90 Aug. 12 at 11:45 PM

$CRIS So oversold bounce is going to be massive

0 · Reply

ralmaral Aug. 12 at 10:18 PM

$CRIS RS again?

1 · Reply

BioHuntingTwits Aug. 12 at 9:24 PM

$CRIS From every possible angle, something here just doesn’t add up for me with the company’s low market cap. Even after accounting for the latest share dilution, the valuation still seems extremely low for a company with a Phase 1/2 program showing promising early results (albeit based on a small number of patients Any idea?

3 · Reply

jsmith14 Aug. 12 at 8:24 PM

$CRIS earnings must be good

0 · Reply

MSG8898 Aug. 12 at 7:38 PM

$CRIS

0 · Reply

MSG8898 Aug. 12 at 6:57 PM

$CRIS going to

0 · Reply

MSG8898 Aug. 12 at 6:57 PM

$CRIS heading toward

0 · Reply

MSG8898 Aug. 12 at 6:19 PM

$CRIS these dudes sank the company

0 · Reply

Unburdened Aug. 12 at 6:01 PM

$CRIS Absolute garbage

0 · Reply

Market Cap	3.76M
Revenue (ttm)	9.44M
Net Income (ttm)	-7.58M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-80.30%
Debt to Equity Ratio	0.00

Volume	280,200
Avg Vol	327,232
Day's Range	N/A - N/A
Shares Out	2.09M
Stochastic %K	5%
Beta	3.13
Analysts	Sell
Price Target	$31.50